دورية أكاديمية
A Fatal Case of Neuroleptic Malignant Syndrome After Paralytic Bowel in a Patient Taking Antiparkinson Medication.
| العنوان: | A Fatal Case of Neuroleptic Malignant Syndrome After Paralytic Bowel in a Patient Taking Antiparkinson Medication. |
|---|---|
| المؤلفون: | Campa D; Department of Emergency Medicine, Pineta Grande Hospital, Caserta, Italy., Ariello M; Department of Emergency Medicine, Pineta Grande Hospital, Caserta, Italy., Castaldo R; Department of Emergency Medicine, Pineta Grande Hospital, Caserta, Italy., Zibella F; Department of Emergency Medicine, Pineta Grande Hospital, Caserta, Italy., Ferrazza P; LN Age, Roma, Italy., Del Gaudio S; Department of Emergency Medicine, Pineta Grande Hospital, Caserta, Italy. |
| المصدر: | European journal of case reports in internal medicine [Eur J Case Rep Intern Med] 2016 May 18; Vol. 3 (4), pp. 000368. Date of Electronic Publication: 2016 May 18 (Print Publication: 2016). |
| نوع المنشور: | Journal Article |
| اللغة: | English |
| بيانات الدورية: | Publisher: SMC Media Country of Publication: Italy NLM ID: 101648453 Publication Model: eCollection Cited Medium: Internet ISSN: 2284-2594 (Electronic) Linking ISSN: 22842594 NLM ISO Abbreviation: Eur J Case Rep Intern Med Subsets: PubMed not MEDLINE |
| أسماء مطبوعة: | Original Publication: Milano : SMC Media, [2014]- |
| مستخلص: | Objectives: We report a fatal case of neuroleptic malignant-like syndrome, which occurred as a consequence of paralytic bowel in a 72-year-old woman on treatment with antiparkinson medication. Case Description: Contrast enhanced computerized tomography of the chest and abdomen demonstrated the presence of paralytic bowel. Results: The patient died. Conclusions: Physicians involved in the treatment of patients affected by Parkinson's disease should take into consideration the possibility of dopaminergic drug malabsorption due to paralytic bowel as a possible cause of neuroleptic malignant-like syndrome. Learning Points: Clinical features of neuroleptic malignant-like syndrome (NMLS) in parkinsonian patients are similar to those of neuroleptic malignant syndrome (NMS), which is a potentially fatal condition associated with the withdrawal of antipsychotic medication.Paralytic bowel is a condition frequently impairing medication absorption in the absence of modifications to the normal daily intake of antiparkinson drugs.The present case report describes the fatal outcome of NMLS following paralytic bowel in a parkinsonian patient on levodopa and amantadine therapy. Competing Interests: Conflicts of Interests: The Authors declare that there are no competing interests. |
| References: | J Neurol Neurosurg Psychiatry. 2001 Jul;71(1):111-3. (PMID: 11413275) Mov Disord. 2005 Dec;20(12):1671; author reply 1671-2. (PMID: 16149099) J Clin Psychiatry. 2011 Sep;72(9):1222-8. (PMID: 21733489) Neurohospitalist. 2011 Jan;1(1):41-7. (PMID: 23983836) Acta Biomed. 2014 Dec 17;85(3):281-4. (PMID: 25567468) |
| فهرسة مساهمة: | Keywords: Neuroleptic malignant-like syndrome (NMLS); Paralytic bowel (PB); Parkinson’s disease (PD) |
| تواريخ الأحداث: | Date Created: 20190214 Latest Revision: 20220331 |
| رمز التحديث: | 20221213 |
| مُعرف محوري في PubMed: | PMC6346863 |
| DOI: | 10.12890/2016_000368 |
| PMID: | 30755870 |
| قاعدة البيانات: | MEDLINE |
Full Text Finder كن أول من يترك تعليقا!